4TY8
An Ligand-observed Mass Spectrometry-based Approach Integrated into the Fragment Based Lead Discovery Pipeline
Entity
| Entity ID | Chain ID | Description | Type | Chain length | Formula weight | Number of molecules | DB Name (Accession) | Biological source | Descriptive keywords |
| 1 | A, C, D (A, C, D) | Polyprotein | polymer | 566 | 62792.0 | 3 | UniProt (D0PY27) Pfam (PF00998) | Hepatitis C virus | |
| 2 | B (B) | Polyprotein | polymer | 566 | 62737.0 | 1 | UniProt (D0PY27) Pfam (PF00998) | Hepatitis C virus | |
| 3 | E, F (A, B) | 6-methyl-2H-chromen-2-one | non-polymer | 160.2 | 2 | Chemie (3AV) |
Sequence modifications
B: 1 - 566 (UniProt: D0PY27)
| PDB | External Database | Details |
|---|---|---|
| Met 550 | Trp 550 | engineered mutation |
Sequence viewer
Contents of the asymmetric unit
| Polymers | Number of chains | 4 |
| Total formula weight | 251112.9 | |
| Non-Polymers* | Number of molecules | 2 |
| Total formula weight | 320.3 | |
| All* | Total formula weight | 251433.3 |
